Indian Journal of Pharmaceutical Education and Research logo
Article

Role of Brain Ang (1-7) With Combination Therapy of Aliskerin in Control of Diabetic Nephropathy

1, 1, 2

  1. 1Department of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, INDIA.
  2. 2Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, Uttar Pradesh, INDIA.

CORRESPONDENCE

Ms. Richa Shakya

Department of Pharmacology Institute of Pharmaceutical Research, GLA University, Mathura-281406, Uttar Pradesh, INDIA.

richa.shakya@yahoo.com

Received: 11-12-2023; Revised: 17-05-2024; Accepted: 23-12-2024.

Volume 59, Issue 2s (Supplement) · pp. s633-s640 · 2025 · DOI: 10.5530/ijper.20255883

ABSTRACT

Objectives: Angiotensin (1-7) system has been recognizing as physiologically major content of the renin-angiotensin system. It exhibited that Diabetic Nephropathy (DN), which is prevalent causes of end-stage renal disease, reduces Ang (1-7) peripheral activity. RAS activity in the PNS is controlled by RAS in the brain. The goal of this research is to see whether cerebral angiotensin (1-7) has a role in chronic diabetic kidney disease in wistar rats.Materials and Methods: Single dosage of streptozotocin 35 mg/kg i.p causes Diabetes Mellitus (DM). 2 doses of aliskerin and Ang (1-7) via a various route. After that there were testing of the samples. Commercially available kits were used to determine biochemical parameters linked to DN.Results: When streptozotocin was given to diabetic rats for 10 weeks, the mice displayed higher serum creatinine, blood urea as well as protein in urine, as well as a decreased amount of serum nitrite. A 2-week course of intracerebral aliskerin (100 nmol/day) and Ang (1-7) treatment decreased such changes also elevated serum nitrite in rats with DN, but only in conjunction with Ang (1-7) (4.8 g/day) separately or in combinations.Conclusion: The findings of current research imply that brain Ang (1-7) is vital in RAS peripheral activity modulation in diabetic nephropathy, which might be attributed to Ang II peripheral activity and reduced central sympathetic outflow.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Shakya, R., Gupta, J. K., & Mazumder, A. (2025). Role of Brain Ang (1-7) With Combination Therapy of Aliskerin in Control of Diabetic Nephropathy. Indian Journal of Pharmaceutical Education and Research, 59(2s), s633-s640. https://doi.org/10.5530/ijper.20255883

    Copyright and licence

    © 2025 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0